Depression is highly prevalent and is associated with poor quality of life and increased
mortality among adults with chronic kidney disease (CKD), including those with end-stage …

Prevalence estimates of depression in chronic kidney disease (CKD) vary widely in existing
studies. We conducted a systematic review and meta-analysis of observational studies to …

Patients with advanced chronic kidney disease (CKD) have a high burden of physical and
psychosocial symptoms, poor outcomes, and high costs of care. Current paradigms of care …

Fatigue is a commonly reported and debilitating symptom among patients with CKD, yet little
is known about its epidemiology, pathogenesis, and treatment. Various measurement tools …

Depression is a common, under-recognized, and under-treated problem that is
independently associated with increased morbidity and mortality in CKD patients. However …

Objective We aimed to evaluate the validity and reliability of multiple screening measures for
depression and anxiety for use in the clinical care of people with multiple sclerosis (MS) …

Context Patients with chronic kidney disease (CKD) experience increased rates of
hospitalization and death. Depressive disorders are associated with morbidity and mortality …

BACKGROUND: Depression is related to morbidity and mortality in patients with kidney
failure treated by dialysis, but its influence on patients with earlier stages of chronic kidney …

Background Depression is prevalent in patients with chronic kidney disease (CKD) and has
been associated with increased morbidity and mortality. Whereas the point prevalence of …

Importance Major depressive disorder (MDD) is prevalent among patients with chronic
kidney disease (CKD) and is associated with morbidity and mortality. The efficacy and …